2014 Fiscal Year Final Research Report
Development of cell-specific essential peptide matrix (EP-Matrix)
Project/Area Number |
25560228
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Biomedical engineering/Biomaterial science and engineering
|
Research Institution | Tokyo University of Pharmacy and Life Science |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
KIKKAWA Yamato 東京薬科大学, 薬学部, 准教授 (20274227)
HOZUMI Kentaro 東京薬科大学, 薬学部, 講師 (10453804)
KATAGIRI Fumihiko 東京薬科大学, 薬学部, 助教 (60420642)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Keywords | バイオマテリアル / 細胞外マトリックス / 基底膜 / ラミニン / ペプチド / マトリックス / 細胞接着 / キトサン |
Outline of Final Research Achievements |
Sixty active peptides derived from laminin-111 were conjugated onto a chitosan matrix and examined their biological activity using fibroblasts and neuronal cells. Twenty-six peptide-chitosan matrices promoted biological activities and were categorized into five groups depending on their activities. The most active peptide-chitosan matrices were selected in each group as an essential peptide matrix. Additionally, the effect of spacer on the biological activity of each peptide-chitosan matrix was examined using various lengths of spacers. The spacer-optimization for each peptide is important for designing effective peptide-chitosan matrices. The mixed essential peptide-chitosan matrices with the optimized spacer are useful as a biomaterial for tissue engineering.
|
Free Research Field |
生化学
|